Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G

Clinical Impact of HAb18G/CD147 Expression in Esophageal Squamous Cell Carcinoma

(2011) Shaojun Zhu et al.   DIGESTIVE DISEASES AND SCIENCES

Expression of CD147 is associated with prostate cancer progression

(2011) Wei-de Zhong et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma

(2010) Fangfang Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Receptor Activator of NF- B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147

(2010) N. Rucci et al.   CANCER RESEARCH

CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer

(2010) Yi-Jun Xue et al.   MEDICAL ONCOLOGY

The interaction of HAb18G/CD147 with integrin α6β1 and its implications for the invasion potential of human hepatoma cells

(2009) Jing-yao Dai et al.   BMC CANCER

The New Lung Cancer Staging System

(2009) Frank C. Detterbeck et al.   CHEST

HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection

(2009) Yu Li et al.   HISTOPATHOLOGY

Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism

(2008) Miyako Baba et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9

(2008) Wulf Sienel et al.   MODERN PATHOLOGY

Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion

(2008) D. Belotti et al.   MOLECULAR CANCER RESEARCH